Rescale Achieves AWS Life Sciences Competency
Blog post from Rescale
Rescale has achieved AWS Life Sciences Competency partner status, complementing its existing AWS Manufacturing & Industrial and Government Competency recognitions, which underscores its expertise in delivering high-performance computing (HPC) services to life sciences customers. This achievement enhances Rescale's ability to support AWS life sciences clients by accelerating innovation and digital transformation in research and development (R&D) programs. The partnership aims to address the challenges faced by biopharmaceutical companies, particularly the high costs and risks associated with drug discovery, by offering scalable, on-demand supercomputing infrastructure to facilitate computational science efforts. Rescale simplifies the complexities of HPC cloud migration by providing a platform that supports a wide range of applications and computing architectures, enabling life sciences organizations to conduct extensive simulations in areas such as computer-aided drug design and genomic sequencing. This collaboration is positioned to help biopharmaceutical companies streamline their R&D processes, reduce costs, and bring new therapies to market more efficiently.
No tracked trend matches for this post yet.
Use this post, company, and trend context to find content marketing opportunities, perform competitive analysis, or address product feature gaps via the Plushcap MCP server or the Plushcap API.